Login to Your Account



Santarus' Uceris Beats Asacol, Placebo in Ulcerative Colitis

By Catherine Shaffer
Staff Writer

Friday, September 28, 2012
Results from the CORE I trial of Uceris (budesonide) in ulcerative colitis appeared in Gastroenterology, detailing a statistically significant benefit over placebo for inducing remission of the disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription